Browse by Basel Contributors ID

Yes

Shende, P. and Plaisance, I. and Morandi, C. and Pellieux, C. and Berthonneche, C. and Zorzato, F. and Krishnan, J. and Lerch, R. and Hall, M. N. and Ruegg, M. A. and Pedrazzini, T. and Brink, M.. (2011) Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation, 123 (10). pp. 1073-1082.

Grussenmeyer, T. and Meili-Butz, S. and Roth, V. and Dieterle, T. and Brink, M. and Winkler, B. and Matt, P. and Carrel, T. P. and Eckstein, F. S. and Lefkovits, I. and Grapow, M. T.. (2011) Proteome analysis in cardiovascular pathophysiology using Dahl rat model. Journal of proteomics, Vol. 74, H. 5. pp. 672-682.

Häuselmann, Stéphanie P. and Rosc-Schlüter, Berit I. and Lorenz, Vera and Plaisance, Isabelle and Brink, Marijke and Pfister, Otmar and Kuster, Gabriela M.. (2011) β1-Integrin is up-regulated via Rac1-dependent reactive oxygen species as part of the hypertrophic cardiomyocyte response. Free radical biology & medicine, Vol. 51, H. 3. pp. 609-618.

Hauselmann, S. P. and Rosc-Schluter, B. I. and Lorenz, V. and Plaisance, I. and Brink, M. and Pfister, O. and Kuster, G. M.. (2011) β1-Integrin is up-regulated via Rac1-dependent reactive oxygen species as part of the hypertrophic cardiomyocyte response. Free radical biology & medicine, Vol. 51, H. 3. pp. 609-618.

Meili-Butz, Silvia and Bühler, Katrin and John, Dietlinde and Buser, Peter and Vale, Wylie W. and Peterson, Kirk L. and Brink, Marijke and Dieterle, Thomas. (2010) Acute effects of urocortin 2 on cardiac function and propensity for arrhythmias in an animal model of hypertension-induced left ventricular hypertrophy and heart failure. European journal of heart failure, Vol. 12, H. 8. pp. 797-804.

Dieterle, T. and Meili-Butz, S. and Bühler, K. and Morandi, C. and John, D. and Buser, P. T. and Rivier, J. and Vale, W. W. and Peterson, K. L. and Brink, M.. (2009) Immediate and sustained blood pressure lowering by urocortin 2 : a novel approach to antihypertensive therapy? Hypertension, Vol. 53. pp. 739-744.

Bühler, K. and Plaisance, I. and Dieterle, T. and Brink, M.. (2009) The human urocortin 2 gene is regulated by hypoxia : identification of a hypoxia-responsive element in the 3'-flanking region. Biochemical journal : BJ, Vol. 424. pp. 119-127.

Keller, Dagmar I. and Grenier, Julie and Christé, Georges and Dubouloz, Frédérique and Osswald, Stefan and Brink, Marijke and Ficker, Eckhard and Chahine, Mohamed. (2009) Characterization of novel KCNH2 mutations in type 2 long QT syndrome manifesting as seizures. The Canadian journal of cardiology = Journal canadien de cardiologie, Vol. 25. pp. 455-462.

Bentzinger, C. F. and Romanino, K. and Cloëtta, D. and Lin, S. and Mascarenhas, J. B. and Oliveri, F. and Xia, J. and Casanova, E. and Costa, C. F. and Brink, M. and Zorzato, F. and Hall, M. N. and Rüegg, M. A.. (2008) Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metabolism, 8 (5). pp. 411-424.

Meili-Butz, S. and Niermann, T. and Fasler-Kan, E. and Barbosa, V. and Butz, N. and John, D. and Brink, M. and Buser, P. T. and Zaugg, C. E.. (2008) Dimethyl fumarate, a small molecule drug for psoriasis, inhibits Nuclear Factor-kappaB and reduces myocardial infarct size in rats. European Journal of Pharmacology, Vol. 586. pp. 251-258.

Plaisance, I. and Morandi, C. and Murigande, C. and Brink, M.. (2008) TNF-alpha increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK. American journal of physiology. Endocrinology and metabolism, Vol. 294, H. 2 , E241-250.